BFM Podcast

Author: Tan KW   |   Latest post: Tue, 21 May 2019, 1:30 PM


Doctor in the House: Biosimilar Drugs – Making Cancer Treatment Affordable

Author:   |    Publish date:

Dr George Lee, Consultant Urologist | Datin Paduka Prof Dr Teo Soo Hwang, CEO, Cancer Research Malaysia

14-Dec-18 17:00


Dr George Lee returns to discuss the latest medical news. Expect deep insights delivered with generous humour. Earlier this week, the Health Ministry announced  that it has approved the biosimilar version of trastuzumab, a targeted therapy for women with HER2-positive breast cancer. The biosimilar version will significantly reduce the cost of treatment, which currently costs RM130,000 a year. Datin Paduka Prof Dr Teo Soo Hwang, CEO of Cancer Research Malaysia, joins us to discuss how biosimilar therapies can improve accessibility to cancer care.


Produced by: Tee Shiao Eek

Presented by: Meera Sivasothy

Share this

  Be the first to like this.


239  441  452  780 

Top 10 Active Counters
 BARAKAH 0.07-0.015 
 LAMBO 0.065-0.005 
 ARMADA 0.19-0.005 
 PHB 0.0250.00 
 VC-PA 0.07-0.005 
 IMPIANA 0.035-0.01 
 LAMBO-WB 0.010.00 
 NIHSIN-WB 0.06-0.02 
 TIGER 0.045+0.005 
 IOIPG 1.190.00 
Partners & Brokers